These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14830335)

  • 21. Rabies vaccination in Japan.
    Wilde H; Hemachudha T
    Vaccine; 2009 Jan; 27(2):181. PubMed ID: 19007834
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aspects of the immunogenic capacities of the fixed Babeş rabies virus to vaccines prepared from nerve tissue of different categories of experimental animals].
    Serban O; Toacsen E; Potorac E; Bunea M; Pandele E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1983; 28(1):41-8. PubMed ID: 6635460
    [No Abstract]   [Full Text] [Related]  

  • 23. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oral immunization of foxes against rabies: stabilization and use of bait for virus application].
    Häfliger U; Bichsel P; Wandeler A; Steck F
    Zentralbl Veterinarmed B; 1982 Sep; 29(8):604-18. PubMed ID: 7180249
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effectiveness of combined vaccination with cultured rabies vaccine and gamma-globulin in experiments on dogs with street virus rabies].
    Gribencha SV; Selimov MA
    Vopr Virusol; 1969; 14(5):584-7. PubMed ID: 4110826
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fluorescence diagnosis of rabies and its advantages for rabies vaccination].
    Winkler C; Patzwaldt HG
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):179-90. PubMed ID: 4171966
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1.
    Thisyakorn U; Pancharoen C; Ruxrungtham K; Ubolyam S; Khawplod P; Tantawichien T; Phanuphak P; Wilde H
    Clin Infect Dis; 2000 Jan; 30(1):218. PubMed ID: 10619765
    [No Abstract]   [Full Text] [Related]  

  • 28. A model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus.
    Blancou J; Andral B; Andral L
    J Gen Virol; 1980 Oct; 50(2):433-5. PubMed ID: 7463005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies.
    Pastoret PP; Brochier B; Boulanger D
    Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953
    [No Abstract]   [Full Text] [Related]  

  • 30. A tissue-culture, modified live-virus rabies vaccine for dogs: report on development and clinical trial.
    Emery JB; Elliott AY; Bordt DE; Burch GR; Kugel EE
    J Am Vet Med Assoc; 1968 Mar; 152(5):476-82. PubMed ID: 5637640
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Wu W; Liu S; Yu P; Tao X; Lu X; Yan J; Wang Q; Zhang Z; Zhu W
    Arch Virol; 2017 Jun; 162(6):1701-1703. PubMed ID: 28188373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with antirabies vaccination of foxes using the oral route coordinated among several European countries and perspectives on the use of recombinant vaccinia-rabies virus].
    Pastoret PP; Blancou J; Brochier B; Thomas I; Paquot A; Debruyn J; Costy F; Wolff F; Kieny MP; Languet B
    Parassitologia; 1988; 30(1):149-54. PubMed ID: 3268767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccination.
    Orłowska A; Żmudziński JF
    Arch Virol; 2015 Feb; 160(2):509-15. PubMed ID: 25408374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress towards rabies control.
    Ferguson M
    Trends Biotechnol; 1991 Jan; 9(1):7-11. PubMed ID: 1366926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vaccination prophylaxis--a Danaid sieve? A colloquium at the Pasteur Institute (Paris) on rabies vaccination then and today].
    Schneider RE
    Fortschr Med; 1985 Sep; 103(34):60-1. PubMed ID: 4076979
    [No Abstract]   [Full Text] [Related]  

  • 36. Additional thoughts on human rabies vaccination.
    Rupprecht CE
    J Am Vet Med Assoc; 2006 Jul; 229(2):206; author reply 206-7. PubMed ID: 16865814
    [No Abstract]   [Full Text] [Related]  

  • 37. Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine.
    Jas D; Coupier C; Toulemonde CE; Guigal PM; Poulet H
    Vaccine; 2012 Nov; 30(49):6991-6. PubMed ID: 23059358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of an inactivated rabies virus vaccine in domestic ferrets.
    Rupprecht CE; Gilbert J; Pitts R; Marshall KR; Koprowski H
    J Am Vet Med Assoc; 1990 May; 196(10):1614-6. PubMed ID: 2347753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral vaccination in the control of feral rabies].
    Biocca E; Bellani L
    Parassitologia; 1988; 30(1):3-12. PubMed ID: 3268770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Specific and nonspecific humoral response to vaccination with the anti-rabies vaccination agents Rabivac and Vnukovo-32].
    Wiedermannová D; Wiedermann D; Svrcek S; Novotná D; Macků M; Závadová J; Benísek Z
    Cas Lek Cesk; 1983 Aug; 122(32-33):980-3. PubMed ID: 6627311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.